News/ R&D Biofrontera mulls US IPO to fund skin cancer drug Richard Staines BioFrontera, cancer, IPO, regulation, skin cancer 0 Comment German biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin Share X Biofrontera mulls US IPO to fund skin cancer drug https://pharmaphorum.com/news/biofrontera-considers-us-listing-fund-skin-cancer-drug/
